neurological disorders

A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury

Study Overview The clinical trial investigated the efficacy of MLC901, also known as NeuroAiD II, in addressing cognitive deficits resulting

A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury Read Post »

Differential DNA Methylation of the Brain-Derived Neurotrophic Factor Gene is Observed after Pediatric Traumatic Brain Injury Compared to Orthopedic Injury

Study Overview The study investigates the differential methylation patterns of the brain-derived neurotrophic factor (BDNF) gene following pediatric traumatic brain

Differential DNA Methylation of the Brain-Derived Neurotrophic Factor Gene is Observed after Pediatric Traumatic Brain Injury Compared to Orthopedic Injury Read Post »

Adaptive trial for the treatment of depressive symptoms associated with concussion using accelerated intermittent theta burst stimulation (ADEPT): rationale, design and methods

Study Overview The ADEPT trial is designed to investigate the effectiveness of accelerated intermittent theta burst stimulation (iTBS) as a

Adaptive trial for the treatment of depressive symptoms associated with concussion using accelerated intermittent theta burst stimulation (ADEPT): rationale, design and methods Read Post »

Scroll to Top